KRYSTAL BIOTECH INC's ticker is KRYS and the CUSIP is 501147102. A total of 188 filers reported holding KRYSTAL BIOTECH INC in Q2 2023. The put-call ratio across all filers is 0.86 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,866,556 | +1.2% | 16,091 | +2.4% | 0.36% | +5.3% |
| Q2 2023 | $1,844,824 | -6.8% | 15,714 | -36.5% | 0.34% | -12.1% |
| Q1 2023 | $1,979,644 | -24.8% | 24,727 | -25.6% | 0.39% | -28.6% |
| Q4 2022 | $2,633,669 | +13.0% | 33,245 | -0.6% | 0.54% | +7.5% |
| Q3 2022 | $2,331,000 | +15.9% | 33,439 | +9.2% | 0.51% | +3.3% |
| Q2 2022 | $2,011,000 | -10.8% | 30,630 | -9.6% | 0.49% | +16.9% |
| Q1 2022 | $2,254,000 | -7.6% | 33,878 | -2.8% | 0.42% | +5.0% |
| Q4 2021 | $2,439,000 | -18.8% | 34,867 | -49.8% | 0.40% | -57.1% |
| Q1 2020 | $3,002,000 | -17.2% | 69,430 | +6.1% | 0.93% | +16.9% |
| Q4 2019 | $3,625,000 | +18.7% | 65,463 | -25.5% | 0.80% | -1.2% |
| Q3 2019 | $3,053,000 | -6.9% | 87,914 | +7.9% | 0.81% | +0.6% |
| Q2 2019 | $3,280,000 | +336.8% | 81,447 | +256.9% | 0.80% | +335.9% |
| Q1 2019 | $751,000 | +9.5% | 22,821 | -30.9% | 0.18% | -1.1% |
| Q4 2018 | $686,000 | – | 33,025 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 1,913,280 | $153,177,197 | 6.65% |
| Frazier Life Sciences Management, L.P. | 945,407 | $75,689,284 | 5.48% |
| S Squared Technology, LLC | 108,215 | $8,663,693 | 5.14% |
| Nicholas Investment Partners, LP | 374,718 | $29,999,923 | 2.28% |
| Avoro Capital Advisors LLC | 1,750,000 | $140,105,000 | 2.08% |
| Artal Group S.A. | 412,082 | $32,991 | 1.96% |
| First Light Asset Management, LLC | 195,980 | $15,690,159 | 1.41% |
| Integral Health Asset Management, LLC | 85,000 | $6,805,100 | 1.37% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 61,000 | $4,883,660 | 1.36% |
| Hood River Capital Management LLC | 447,393 | $35,818,000 | 1.16% |